Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

361 Capital launches Global Macro fund

Thursday, July 10, 2014

Bailey McCann, Opalesque New York:

Denver-based 361 Capital has launched its Global Macro Opportunities Fund and will wrap a global macro strategy in the mutual fund structure. As Opalesque has previously reported, 361 Capital is already in the market with other liquid alternative funds.

The global macro fund will be managed by Blaine Rollins, who joined 361 Capital in 2011 and was formerly a portfolio manager at Janus. Rollins is known for his weekly 361 research note, which is widely distributed.

"We launched the Global Macro Opportunity Fund in part because we heard from advisors who wanted to be able to invest in the ideas that Blaine expresses in his weekly commentary," said Tom Florence, CEO of 361 Capital. "This is a great addition to our line-up as we continue to build out our roster of liquid alternative mutual funds for advisors and their clients."

The fund will maintain exposures to U.S. and foreign equity securities, fixed income securities, commodities and currencies. Like other funds in this strategy group, Rollins will make opportunistic investments across a range of asset classes and indices. The fund is expected to be classified in the Morningstar Multialternative category and its objective is to seek long-term positive absolute return.

The 361 Global Macro Opportunity Fund is available through the major platforms, including Schwab, Fidelity, TD Ameritrade, Pershing and others.

......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner